drugset
Drugs / [F-18]-Fludeoxyglucose
last change Jan 2017 re-read 3 minutes ago

[F-18]-Fludeoxyglucose

Diagnostic / imaging agent

Investigated by
Saskatoon Health Region · Sylvia Fedoruk Canadian Centre for Nuclear Innovation · University of Saskatchewan

Trials 1

today NCT02811185 · Ph 4
20172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT02811185 Jun 2016 → Jan 2017 — University of Saskatchewan Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as [F-18]-Fludeoxyglucose ClinicalTrials.gov intervention name — accepted as the source's own label NCT02811185 ↗
Modality Diagnostic / imaging agent “Radiopharmaceutical imaging agent” NCT02811185 ↗